Try our beta test site

A Study of Strawberries and Disease Risk (STRB)

This study is ongoing, but not recruiting participants.
California Strawberry Commission
Information provided by (Responsible Party):
Institute for Food Safety and Health, United States Identifier:
First received: September 9, 2010
Last updated: February 6, 2017
Last verified: February 2017
The purpose of this study is to test whether compounds found in strawberries (polyphenolics which are typically found in berry products, tea, coffee, red wine, and chocolate) will help reduce insulin resistance and inflammation, known factors in your blood associated with disease risk, when eaten with a standard high fat/carbohydrate meal.

Condition Intervention
Nutritional and Metabolic Diseases
Physiological Responses
Dietary Supplement: Placebo
Dietary Supplement: 10G
Dietary Supplement: 20G
Dietary Supplement: 40G
Dietary Supplement: Placebonofiber

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Participant
Primary Purpose: Basic Science
Official Title: Effect of Strawberry on Oxidative Stress- and Inflammatory-mediated Insulin Resistance (IR) in Humans: Combating a Major Risk Factor for Diabetes and Cardiovascular Disease Through Diet

Further study details as provided by Institute for Food Safety and Health, United States:

Primary Outcome Measures:
  • The ability of strawberries to modulate postprandial oxidative stress and inflammation in insulin-resistant men and women in an acute postprandial paradigm [ Time Frame: 6 hour postprandial study over 4-6 week period ]

Secondary Outcome Measures:
  • The ability of strawberries plus fiber to understand insulin signaling in insulin resistant individuals. [ Time Frame: 6 hours postprandial study over 2-week period ]

Enrollment: 25
Study Start Date: September 2010
Estimated Study Completion Date: October 2017
Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Placebo
Dietary Supplement: Placebo
whole milk shake without strawberry powder served with the high fat/carbohydrate test meal
Other Name: Pbo
Experimental: 10G STRB powder
Dose 1
Dietary Supplement: 10G
whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal
Other Name: Dose 1
Experimental: 20G STRB powder
Dose 2
Dietary Supplement: 20G
whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal
Other Name: Dose 2
Experimental: 40G STRB powder
Dose 3
Dietary Supplement: 40G
whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal
Other Name: Dose 3
Placebo Comparator: PlacebonoFiber
Placebo without fiber
Dietary Supplement: Placebonofiber
Placebo without Fiber

  Hide Detailed Description

Detailed Description:

The main study is a single-center, randomized, cross-over, 4-arm, dose-response, single- blinded, 6-hour postprandial study to evaluate the ability of strawberry powder to block meal-induced oxidative stress and inflammation and concomitantly improve postprandial insulin sensitivity and glucose handling.

A planned sample size of 45 will be recruited into the study. Thirty subjects for the main study and 15 subjects for the complement study. Subjects can participate in both studies and if subjects participate in both studies, there will be a time gap between the main study and the complement study due to the volume of blood permitted to collect within 56 days.

The complement study will be a 2-arm placebo controlled study following the exact same protocol as the main study, but using only one strawberry dose (Dose 3 as in the main study) and comparing the effects relative to a placebo that does not control for fiber.

The main study will take 5- 6 weeks per subject to complete and the complement study will take 1-2 weeks per subject to complete, depending on subject's schedule.

The procedures conducted at the screening visit include blood sampling by finger prick for a fasting blood sugar test and anthropometric measurements (height, weight, and waist circumference), vital sign measurements (blood pressure and heart rate) and completion of a series of questionnaires relating to volunteers' general health and eating habits. Volunteers may be asked to complete an oral glucose/sugar tolerance test (OGTT) at screening. Volunteers will be exempt from the OGTT procedure if other qualifying conditions are present. Briefly, subjects undergoing OGTT will be asked to drink a glucose drink (similar in taste to kool-aid) in the morning after a 10 hour fast. Blood glucose finger pricks will then be done at 1 hour and 2 hours for determination of glucose tolerance. If the OGTT is necessary, additional compensation will be provided.

If qualified, subjects will undergo a 7-day pre-study period during which they will be asked to record their usual diet intake for 3 days, including 2 weekdays and 1 weekend day, EITHER followed by randomization into 1 of 4 treatment beverage sequences for the main study: Placebo (Pbo), Strawberry Dose 1, Strawberry Dose 2 and Strawberry Dose 3, OR followed by randomization into 1 of 2 treatment (Placebo without fiber and Strawberry Dose 3) beverage sequences for the complement study.

We expect it to be very difficult to eliminate or severely restrict polyphenolic diet during the entire study period, therefore subjects will be asked to limit only berry product intake during the study period. However, subjects will be asked to limit all polyphenolic foods in their diet for 3 days prior to each study visit.

All subjects will consume the standard high fat/ carbohydrate meal (known to induce oxidative- and inflammatory- stress) accompanied by 1 of 4 test beverages (whole milk shake with or without strawberry powder) on four separate occasions for the main study OR 1 of 2 test beverages on two separate occasions for the complement study, so that each subject will serve as their own control.

Subjects will arrive at the study visits fasted for at least 10 hours, well hydrated and rested. Each study visit will require blood draws throughout the visit. After pre-study procedures (height, weight, waist circumference, blood pressure, blood glucose finger prick) and while fasting, a registered nurse (RN) will place a catheter (flexible tubing) in subjects' arm for the purpose of drawing blood. This catheter will remain only throughout the study day. Approximately 1 tablespoon of blood will be taken at this time. The test meal and strawberry shake will be served and thereafter subjects will have blood draws (1 T each time) at designated time points for the next 6 hours. Each visit will last approximately 7 hours and subjects will be required to remain at the Clinical Nutrition Research Center on the IIT Campus for the duration of the visit. Blood samples will be collected at designated time points during the postprandial period for analysis of metabolic (insulin and glucose homeostasis), oxidative and inflammatory endpoint markers.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

Eligible volunteers must meet ONE or MORE of the criteria (numbers 1-4) associated with insulin resistance along with all of the other criteria listed (numbers 5-9):

  1. Blood glucose concentration between140-199 mg/dL at 2hr from OGTT.
  2. Elevated fasting glucose (≥110 mg/dL and <126 mg/dL)
  3. Elevated fasting insulin (>75th percentile cutoff of 13.13 μU/mL)
  4. Insulin resistance defined by the homeostasis model assessment method of insulin resistance (HOMA-IR) (glucose [in millimoles per liter] × insulin [in microunits per milliliter]/22.5) values of at least 2.5.
  5. Waist circumference >102 cm (men) and > 88 cm (women) for screening visit invitation because many epidemiology studies have been shown that waist circumferences may be related to insulin resistance.
  6. Nonsmokers
  7. Not taking any medications that would interfere with outcomes of the study, i.e. lipid lowering medications, anti-inflammatory drugs, or dietary supplements
  8. 18 years of age and older
  9. No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease

Exclusion Criteria:

  • Pregnant and/or lactating
  • Allergy or intolerance to strawberries and dairy products.
  • Current regular consumption of strawberries is > 2 servings per day.
  • Fasting blood glucose ≥ 126 mg/dL. Subjects identified with elevated fasting blood glucose levels will be advised to contact their primary care physician for appropriate follow-up care.
  • Taking over the counter antioxidant supplements or other supplements that may interfere with the study procedures or endpoints.
  • Subjects with unusual dietary habits (e.g. pica).
  • Actively losing weight or trying to lose weight (unstable body weight fluctuations of > 5 kg in a 60 day period).
  • Excessive exercisers or trained athletes.
  • Subjects with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, or other systemic diseases.
  • Addicted to drugs and/or alcohol.
  • Medically documented psychiatric or neurological disturbances.
  • Smoker (past smoker may be allowed if cessation is > 2 years)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01199848

United States, Illinois
Clinical Nutrition Research Center
Chicago, Illinois, United States, 60616
Sponsors and Collaborators
Institute for Food Safety and Health, United States
California Strawberry Commission
Principal Investigator: Indika Edirisinghe, PhD Institute for Food Safety and Health
Principal Investigator: Britt Burton-Freeman, PhD, MS Institute for Food Safety and Health
  More Information

Responsible Party: Institute for Food Safety and Health, United States Identifier: NCT01199848     History of Changes
Other Study ID Numbers: STRB 2010-033
Study First Received: September 9, 2010
Last Updated: February 6, 2017
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by Institute for Food Safety and Health, United States:
insulin resistance
metabolic syndrome

Additional relevant MeSH terms:
Insulin Resistance
Metabolic Diseases
Pathologic Processes
Glucose Metabolism Disorders processed this record on March 29, 2017